Search

everythinglearnresearchcommunity

for

Search:↓

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Hair loss linked to prostate enlargement; stress and family history important factors.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Cyclosporin doesn't stop hair loss.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Blinking at least 20 times per minute helps maintain eye moisture and reduce dry eye symptoms.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Reducing CD8+ T cell growth can stabilize alopecia areata.

PRP is an effective and safe treatment for alopecia areata.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Low ferritin levels can indicate iron deficiency as a cause of hair loss.

Collagen networks play a key role in hair loss and follicle miniaturization.

Ultrasonic and infrared treatments can improve hair strength and appearance with minimal damage.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Insomnia may increase alopecia areata risk, but more research is needed.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Genetic insights can lead to personalized treatments for acne, androgenetic alopecia, and alopecia areata.

New medications could improve treatment for severe alopecia areata in Australia.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.